Table 4 Table of studies which reported time to treatment as a narrative theme
Author (year) | Outcome | Narrative theme | Type of SACT | Time to treatment |
|---|---|---|---|---|
Ferreira et al. (2020) [36] | Time between diagnosis and commencement of treatment > 60 days | Time to treatment | SACT (treatment) | < 60 days 81.3% |
Ozmen et al. (2015) [37] | Time to receipt of treatment defined as (i) patient delay time (PDT), (ii) system delay time (SDT) and (iii) total delay time = sum of PDT and SDT | Time to treatment | SACT (treatment) | Patient delay time (PDT) 4.8 weeks System delay time (SDT) 10.5 weeks Total delay time (TDT) 13.8 weeks |
Recondo et al. (2019) [38] | Time elapsed between diagnosis and receipt of treatment with chemotherapy | Time to treatment | Chemotherapy | Public hospitals 76 days (64–86) < 0.0001 Private hospitals 60 days (52–65) < 0.0001 |
Vas Luiz et al. (2015) [31] | Time to trastuzumab initiation and utilisation of trastuzumab | Time to treatment | Immunotherapy | White patients 54 days (median), IQR 32–124 (unadjusted) Non-White patients 95 days, IQR 39–167 (unadjusted) < 0.05 |